Stockscreener 앱 받기
29.37
1.81%
-0.54
전일 마감가:
$29.91
열려 있는:
$30.06
하루 거래량:
130.72K
Relative Volume:
0.99
시가총액:
$464.55M
수익:
-
순이익/손실:
$-61.23M
주가수익비율:
-2.1724
EPS:
-13.5194
순현금흐름:
$22.49M
1주 성능:
-7.47%
1개월 성능:
-12.33%
6개월 성능:
+54.91%
1년 성능:
+103.68%
1일 변동 폭
$29.16
$30.34
1주일 범위
$29.16
$32.31
52주 변동 폭
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
명칭
Assembly Biosciences Inc
전화
(833) 409-4583
주소
TWO TOWER PLACE, SOUTH SAN FRANCISCO
ASMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
29.37 | 473.09M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-24 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-08-18 | 재개 | H.C. Wainwright | Buy |
| 2025-03-25 | 개시 | Guggenheim | Buy |
| 2024-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-09-13 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-02 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-10-19 | 개시 | Truist | Buy |
| 2019-10-16 | 개시 | Mizuho | Buy |
| 2018-11-19 | 개시 | Leerink Partners | Outperform |
| 2018-10-08 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 개시 | Robert W. Baird | Outperform |
| 2018-04-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 개시 | Jefferies | Buy |
| 2017-05-30 | 개시 | Chardan Capital Markets | Buy |
모두보기
Assembly Biosciences Inc 주식(ASMB)의 최신 뉴스
Technical Analysis: What is Assembly Biosciences Incs 5 year growth outlookNew Guidance & Target Return Focused Stock Picks - baoquankhu1.vn
Returns Recap: Can Assembly Biosciences Inc disrupt its industryVolume Spike & Growth Oriented Trade Recommendations - baoquankhu1.vn
(ASMB) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Risks Report: What is the target price for Assembly Biosciences Inc stockTrade Performance Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Momentum Shift: How liquid is Assembly Biosciences Inc stockWeekly Profit Analysis & Community Trade Idea Sharing Platform - baoquankhu1.vn
Fed Meeting: Is Assembly Biosciences Inc benefiting from innovation trendsTrade Analysis Report & Consistent Profit Trading Strategies - baoquankhu1.vn
Exit Recap: Is Assembly Biosciences Inc impacted by rising ratesLayoff News & Smart Swing Trading Alerts - baoquankhu1.vn
Assembly Biosciences (ASMB) Sees Raised Price Target From Mizuho - GuruFocus
Gains Recap: What is the target price for Assembly Biosciences Inc stockEarnings Growth Report & High Accuracy Buy Signal Tips - baoquankhu1.vn
What are Assembly Biosciences Inc.’s earnings expectationsInsider Buying Signals & Free Real-Time Trading Alerts Every Day - bollywoodhelpline.com
Portfolio Recap: How Assembly Biosciences Inc stock reacts to inflationary pressures2025 Volatility Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Bull Run: Why Assembly Biosciences Inc V7B stock is a must watch tickerJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - Bộ Nội Vụ
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in ‘significantly de-risks’ genital herpes programs - MSN
Assembly Biosciences (ASMB) price target increased by 24.84% to 48.70 - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
How strong is Assembly Biosciences Inc. stock revenue growthWeekly Profit Recap & Precise Trade Entry Recommendations - ulpravda.ru
Aug Sectors: How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
Why Assembly Biosciences Inc. (V7B) stock is a must watch ticker2025 Stock Rankings & Consistent Growth Equity Picks - Улправда
Is Assembly Biosciences Inc. stock attractive after correction2025 AllTime Highs & Short-Term Trading Opportunity Alerts - Улправда
What risks investors should watch in Assembly Biosciences Inc. stockMarket Risk Analysis & Weekly High Conviction Ideas - Улправда
Why Assembly Biosciences Inc. stock remains a top recommendation2026 world cup usa national team third place match star players low block defense winner prediction guide - ulpravda.ru
(ASMB) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Stock Price Up 4% – Time to Buy? - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Trading 4% HigherHere's What Happened - MarketBeat
After 25 Years, Recurrent Genital Herpes Treatment Gains Corporate Partner - Vax-Before-Travel
Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for... - Medical Dialogues
Ellsworth Advisors LLC Acquires New Holdings in Assembly Biosciences, Inc. $ASMB - Defense World
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in 'significantly de-risks' genital herpes programs - MSN
Technical Reactions to ASMB Trends in Macro Strategies - Stock Traders Daily
With 32% ownership, Assembly Biosciences, Inc. (NASDAQ:ASMB) has piqued the interest of institutional investors - Yahoo Finance
Assembly Biosciences price target raised to $40 from $29 at Mizuho - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 6%What's Next? - MarketBeat
GILD Exercises Option to License Assembly Bio's Herpes Programs - WV News
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes - BioSpace
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Sahm
Assembly Biosciences (NASDAQ:ASMB) Receives Buy Rating from HC Wainwright - Defense World
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says HC Wainwright - MSN
Gilead exercises option for Assembly Bio’s herpes treatment programs By Investing.com - Investing.com South Africa
Gilead Sciences (GILD) Licenses Assembly Bio's Herpes Drug Progr - GuruFocus
HC Wainwright & Co. Reiterates Assembly Biosciences (ASMB) Buy Recommendation - Nasdaq
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs - Asianet Newsable
Assembly Biosciences (NASDAQ:ASMB) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Assembly Biosciences rises as Gilead opts to license co's HSV therapies - TradingView — Track All Markets
ASMB: HC Wainwright & Co. Reiterates Buy Rating with $50 PT | AS - GuruFocus
Gilead exercises license for Assembly Biosciences herpes programs - Seeking Alpha
Assembly Biosciences' (ASMB) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Program - PharmiWeb.com
Gilead pays $35M to license pair of HSV assets from Assembly Bio pact - Fierce Biotech
Assembly Biosciences (ASMB) Gains Momentum with Gilead Licensing Deal - GuruFocus
Assembly Biosciences Inc (ASMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):